America's Best Nonprofits
  1. Home
  2. Disease & Disorders
  3. Burlingame, CA
  4. Diabetes Technology Society

Diabetes Technology Society

Diabetes Technology Society is ranked among disease & disorders organizations in Burlingame, CA, with an America's Best Score of 69 out of 100, based on its 2025 Form 990.

  • Burlingame, CA
  • Tax-exempt since 2002
  • EIN: 30-0012730
diabetestechnology.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
69OF 100 Ranked in Burlingame Disease & Disorders How this score is calculated

Organization summary

Diabetes Technology Society is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G80). Contributions are tax-deductible.

533 Airport Blvd Ste 400, Burlingame, CA 94010-2013

Among the 5 scored disease & disorders organizations in Burlingame, Diabetes Technology Society holds 10.4 months of operating reserves (peer median 29.3 months), runs a typical yearly surplus of 8.4% (peers: surplus of 8.4%), and has grown spending 8.4% a year (peers: grown spending 7.4% a year).

In fiscal year 2025 it reported $1,029,388 in revenue and $1,615,150 in expenses, with contributions making up 18.6% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

To facilitate research into the treatment, monitoring, diagnosis and prevention of diabetes.

Main program · fiscal year 2025

  • To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the diabetes technology field, maintaining a Spanish/English dual-language informational website and publishing 204 technical articles and 13 resea… Read more

    To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the diabetes technology field, maintaining a Spanish/English dual-language informational website and publishing 204 technical articles and 13 research articles about diabetes and diabetes technology. Conferences held in 2025, the number of attendees and other projects are as follows:1.tools to distinguish t1d & t2d in adults (tools project)meeting #1: 2/4/2025, 14 Attendeesmeeting #2: 2/5/2025, 14 Attendeesmeeting #3: 5/29/2025: 29 Attendeesmeeting #4: 8/13/2025, 14 Attendees2. Integration of connected diabetes device data into the electronic health record #2 (icode-2)September 18, 2025no. Of attendees: 403. The role of the glycemia risk index diabetes technology meeting (gri meeting)October 27, 2025no. Of attendees: 484. Diabetes technology meeting (in-person) (dtm 2025)October 28-30, 2025no. Of attendees: 5005. The use of cgm to diagnose stage 2 t1d consensus panel (in-person presentation at the 2025 dtm)October 30, 2025 no. Of attendees: 500Ongoing projects:1. Diabetes research hub (drh) - ongoing projectthe drh is a comprehensive data ecosystem designed to accelerate breakthroughs in diabetes research. We empower researchers by unlocking the potential of data trapped in proprietary medical devices and health systems. By creating a secure and user-friendly platform for data collection, analysis, and collaboration, the drh fuels next-generation research using ai and ml to develop personalized and effective solutions for diabetes.2. The dcb open innovation challengein collaboration with diabetes center berneongoing - launched on 4/1/2024 & featured at the dtm 2025 on 10/30/20253. Diabetes technology report(dts podcast)dts launched an ongoing podcast with leaders in the diabetes technology field.4. Saluddiabetes.orgdts launched a Spanish/English dual-language website that summarizes recent publications in diabetes and health for the layperson.5. Optimizing lifestyle interventions for reversing insulin resistance - ongoing projectto analyze medical literature for interventions that improve insulin sensitivity (either by an effect on the liver, muscles, or production of insulin or natural glp-1ra hormone) that could become part of a behavioral tool to be used for people with prediabetes or who are at risk of diabetes to decrease their risk of developing type 2 diabetes.6. Jdst (journal of diabetes science and technology)published 204 technical articles about diabetes and diabetes technology after receiving 628 articles to review.7. Publication of 13 research articles by dts staff listed below:-evaluating the clinical utility of the glycemia risk index.j diabetes sci technol. 2025 Oct 14:19322968251382604. Doi: 10.1177/19322968251382604. Online ahead of print. Pmid: 41216978 Free pmc article.-machine learning to diagnose complications of diabetes. J diabetes sci technol. 2025 Nov;19(6):1650-1670. Doi: 10.1177/19322968251365245. Epub 2025 sep 11. Pmid: 40932163 Free pmc article. Review.-continuous glucose monitoring data analysis 2.0: Functional data pattern recognition and artificial intelligence applications. J diabetes sci technol. 2025 Nov;19(6):1515-1527. Doi: 10.1177/19322968251353228. Epub 2025 aug 14. Pmid: 40814224 Free pmc article.-glucagon-like peptide-1 receptor agonists and peri-procedural aspiration risk. J endocr soc. 2025 Jul 10;9(9):bvaf088. Doi: 10.1210/Jendso/bvaf088. Ecollection 2025 sep. Pmid: 40893948 Free pmc article. Review.-the need to transition from paper to electronic instructions for use for diabetes devices. Npj digit med. 2025 Jun 13;8(1):356. Doi: 10.1038/S41746-025-01720-0. Pmid: 40514391 Free pmc article.-diabetes devices: A growing environmental burden. Diabetes res clin pract. 2025 Aug;226:112307. Doi: 10.1016/J.diabres.2025.112307. Epub 2025 jun 3. Pmid: 40473032 No abstract available.-use of continuous glucose monitoring to diagnose stage 2 type 1 diabetes. J diabetes sci technol. 2025 Jul;19(4):1109-1127. Doi: 10.1177/19322968251333441. Epub 2025 may 30. Pmid: 40444471 Free pmc article. Review.-envisioning tools to help classify type 1 diabetes and type 2 diabetes in new-onset adult diabetes. J diabetes sci technol. 2025 Jul;19(4):1137-1143. Doi: 10.1177/19322968251329055. Epub 2025 mar 28. Pmid: 40152433 Free pmc article.-quantifying environmental waste from diabetes devices in the U.S. Diabetes care. 2025 Jul 1;48(7):1198-1203. Doi: 10.2337/Dc24-2522. Pmid: 40072890.-How to provide additional oversight to ensure that remote patient monitoring for people with diabetes is being used and billed appropriately. Diabetes sci technol. 2025 May;19(3):843-849. Doi: 10.1177/19322968241309357. Epub 2025 jan 16. Pmid: 39819165 Free pmc article.-how the diabetes research hub will modernize and enhance diabetes data utilization. J diabetes sci technol. 2026 Jan;20(1):3-6. Doi: 10.1177/19322968241306129. Epub 2024 dec 21. Pmid: 39707843 Free pmc article.-comparison of the glycemia risk index and time in range in a case series of using automated insulin delivery to improve glycemic control in people with type 1 diabetes and end stage kidney disease on hemodialysis. Diabetes res clin pract. 2025 Jan;219:111940. Doi: 10.1016/J.diabres.2024.111940. Epub 2024 nov 29. Pmid: 39615793 No abstract available.-consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes. J diabetes sci technol. 2025 Jan;19(1):217-245. Doi: 10.1177/19322968241292041. Epub 2024 nov 29. Pmid: 39611379 Free pmc article.

    $1,401,081 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 87¢ went to programs, 13¢ to management and 0¢ to fundraising.

  • Programs $1,401,081
  • Management $214,069
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score69 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves10.4 mo; 8.9 mo in cash7.2 / 25
Financial balance (median margin)+8.4%10.6 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+8.4% / yr11.7 / 15
Track record24 years9.6 / 10
Debt load1.4% of assets10 / 10
Total69.1 → 69
Spending on programs
Not scored; America's Best needs 65%+
87%Meets

Compared with Burlingame peers

MeasureThis organizationPeer median
Operating reserves10.4 mo29.3 mo
Typical margin+8.4%+8.4%
Spending growth+8.4% / yr+7.4% / yr
Debt load1.4%0.5%

Peers: the 5 Burlingame disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$1,029,388Fiscal year 20252022: $1,163,94620222023: $1,379,12420232024: $1,925,69420242025: $1,029,3882025
Expenses$1,615,150Fiscal year 20252022: $1,267,54820222023: $1,103,40020232024: $1,539,24820242025: $1,615,1502025
Total assets$1,420,913Fiscal year 20252022: $1,334,58820222023: $1,611,70220232024: $2,007,87420242025: $1,420,9132025
Total liabilities$20,362Fiscal year 20252022: $11,11820222023: $12,50820232024: $21,56120242025: $20,3622025
Fiscal year ending December 2025
Revenue$1,029,388
Expenses$1,615,150
Net income−$585,762
Net assets$1,400,551

Notable sources of revenue

Percent of total revenue
Contributions$191,000
Program services$792,044
Investment income$46,344
Other (net)$0

Assets / debt

Total assets$1,420,913
Total liabilities$20,362
Net assets$1,400,551

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$1,925,694
Expenses$1,539,248
Net income$386,446
Net assets$1,986,313

Notable sources of revenue

Percent of total revenue
Contributions$1,290,363
Program services$535,680
Investment income$98,426
Other (net)$1,225

Assets / debt

Total assets$2,007,874
Total liabilities$21,561
Net assets$1,986,313

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$1,379,124
Expenses$1,103,400
Net income$275,724
Net assets$1,599,194

Notable sources of revenue

Percent of total revenue
Contributions$967,906
Program services$371,507
Investment income$38,517
Other (net)$1,194

Assets / debt

Total assets$1,611,702
Total liabilities$12,508
Net assets$1,599,194

Compensation

Officers and key employees$297,813
Share of expenses27.0%
Fiscal year ending December 2022
Revenue$1,163,946
Expenses$1,267,548
Net income−$103,602
Net assets$1,323,470

Notable sources of revenue

Percent of total revenue
Contributions$738,153
Program services$418,745
Investment income$7,048
Other (net)$0

Assets / debt

Total assets$1,334,588
Total liabilities$11,118
Net assets$1,323,470

Compensation

Officers and key employees$607,813
Share of expenses48.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?